Study: Drug-Eluting Stents Still Safer Than Bioresorbable Ones

However, researchers are encouraged by parts of the study that suggest a bright future for the devices that can dissolve inside your arteries.

Published: April 28, 2017

In the ongoing study of a dissolvable coronary artery stent, Cleveland Clinic researchers suggest that the most recent study results may not paint an accurate picture of the products potential upside. In the study, heart patients who received the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) fared somewhat worse than those who received the traditional drug-eluting metal stents (DES).